Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Epigenetics Institute, University of Pennsylvania, Philadelphia, PA, United States; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, PA, United States.
Methods Enzymol. 2024;705:25-49. doi: 10.1016/bs.mie.2024.07.009. Epub 2024 Sep 5.
Recent advances in CRISPR-Cas genomic editors have shifted us ever closer to achieving the ultimate therapeutic goal of accomplishing any edit in any cell. However, delivery of this editing machinery to primary cells with high efficiency while avoiding cellular toxicity remains a formidable challenge. Peptide-Assisted Genome Editing (PAGE) provides a simple, modular, and rapid approach for the protein-based delivery of CRISPR-Cas proteins or ribonucleoprotein complexes into primary cells with high efficiency and minimal cytotoxicity. In this chapter, we detail an expression and purification protocol to obtain highly pure Cas9-T6N and opCas12a-T8N PAGE genomic editors. The robustness of this protocol allows for consistent preparations of the purified editors that can be reliably used for the editing of primary and immortalized cells.
CRISPR-Cas 基因组编辑技术的最新进展使我们越来越接近实现将任何编辑内容都能准确地完成在任何细胞中的终极治疗目标。然而,将这种编辑机制高效地递送到原代细胞中,同时避免细胞毒性,仍然是一个艰巨的挑战。肽辅助基因组编辑(PAGE)为基于蛋白质的高效且低细胞毒性的 CRISPR-Cas 蛋白或核糖核蛋白复合物递送到原代细胞提供了一种简单、模块化和快速的方法。在本章中,我们详细介绍了一种表达和纯化方案,以获得高纯度的 Cas9-T6N 和 opCas12a-T8N PAGE 基因组编辑。该方案的稳健性允许对纯化编辑的一致制备,这些编辑可用于原代细胞和永生化细胞的编辑。